- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: afegostat tartrate
Total 524 results
-
University of LouisvilleJames Graham Brown Cancer CenterCompleted
-
Mansoura UniversityCompleted
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveAustralia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveCanada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
-
ACADIA Pharmaceuticals Inc.CompletedAlzheimer's Disease PsychosisUnited Kingdom
-
Vanderbilt UniversityCompleted
-
HealthPartners InstituteTerminatedBreast Cancer | Neurotoxicity | Chemotherapeutic Agent ToxicityUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Triple-negative Breast Cancer | Recurrent Breast Cancer | Estrogen Receptor-negative Breast Cancer | Progesterone Receptor-negative Breast Cancer | HER2-negative Breast Cancer | Hereditary Breast/Ovarian Cancer - BRCA1 | Hereditary Breast/Ovarian Cancer...United States
-
Shanghai Institute of Acupuncture, Moxibustion...RenJi HospitalCompletedUrgency-frequency SyndromeChina
-
Credit Valley EyeCareCanadian Glaucoma Clinical Research CouncilUnknown
-
James AhlgrenWithdrawnProstate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedStage I Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
National Institute of Allergy and Infectious Diseases...National Institute of Allergy and Infectious Diseases@@@Coley Pharmaceutical...Completed
-
Stanford UniversityCompletedSleep Initiation and Maintenance DisordersUnited States
-
University of Alabama at BirminghamCompletedOveractive Bladder | Lower Urinary Tract SymptomsUnited States
-
Peking University People's HospitalUnknown
-
ACADIA Pharmaceuticals Inc.CompletedParkinson's Disease PsychosisSpain, United States, Belgium, Austria, Serbia, Poland, Portugal, Italy, Sweden
-
ACADIA Pharmaceuticals Inc.CompletedParkinson's Disease PsychosisFrance, United States, Bulgaria, Russian Federation, United Kingdom, Ukraine, India
-
National Cancer Institute (NCI)CompletedRecurrent Childhood Rhabdomyosarcoma | Recurrent Adult Soft Tissue Sarcoma | Previously Treated Childhood Rhabdomyosarcoma | Adult Rhabdomyosarcoma | Childhood Alveolar Rhabdomyosarcoma | Childhood Pleomorphic Rhabdomyosarcoma | Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar FeaturesUnited States, Canada, Australia, New Zealand
-
Bausch & Lomb IncorporatedORA, Inc.Completed
-
Karuna TherapeuticsCompletedSchizophreniaUnited States
-
ACADIA Pharmaceuticals Inc.Approved for marketingParkinson's Disease Psychosis
-
Mikkel Bring ChristensenCompletedBlood Pressure | Drug Overdose | Overdose of Beta-adrenergic Blocking DrugDenmark
-
Galderma Brasil Ltda.Eurotrials Brasil Consultores Cientificos LtdaCompletedChronic Persistent Vascular Facial ErythemaBrazil
-
Massachusetts Eye and Ear InfirmaryCompleted
-
Jun LiShanghai Hutchison Pharmaceuticals LimitedUnknownCoronary Artery Disease(CAD)
-
Massachusetts Eye and Ear InfirmaryCompleted
-
Jun LiChina Academy of Chinese Medical SciencesUnknownCoronary Artery Disease(CAD)
-
Meir Medical CenterMeir Hospital, Kfar Saba, IsraelUnknownComplications of Diabetes MellitusIsrael
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedLung CancerUnited States, Australia
-
Buddhist Tzu Chi General HospitalCompleted
-
SanofiCompletedGaucher DiseaseUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, United Kingdom, Bulgaria, Canada, Colombia, India, Israel, Lebanon, Mexico, Russian Federation, Serbia, Tunisia
-
Astellas Pharma Europe B.V.CompletedUrinary Bladder, OveractiveBelgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveChina, Taiwan, India, Korea, Republic of
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1 | Cerebroside Lipidosis Syndrome | Glucocerebrosidase Deficiency Disease | Glucosylceramide Beta-Glucosidase Deficiency Disease | Gaucher Disease, Non-Neuronopathic FormUnited States, Israel, Mexico, Russian Federation, Argentina, Italy
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGaucher DiseaseUnited States, Sweden, India, Netherlands, Austria, Japan, China, Serbia, France, Croatia, Australia, Portugal, Canada, Brazil, Greece, Romania, Russian Federation
-
Vanderbilt UniversityCompletedOrthostatic Hypotension | Autonomic FailureUnited States
-
SK Chemicals Co., Ltd.CompletedOveractive BladderKorea, Republic of
-
PfizerCompletedSmoking CessationUnited States, Spain, Germany, Canada, South Africa, Finland, Denmark, Australia, Argentina, Brazil, Bulgaria, Chile, Mexico, New Zealand, Russian Federation, Slovakia
-
AllerganCompletedOcular Hypertension | Glaucoma, Open-AngleBrazil
-
Genzyme, a Sanofi CompanyCompletedGaucher Disease, Type 1United States, France, Germany, Italy, Brazil, Australia, Argentina, Canada, Egypt, Russian Federation, Spain, United Kingdom
-
Janssen Research & Development, LLCWithdrawn
-
Hanmi Pharmaceutical Company LimitedCompleted
-
French Innovative Leukemia OrganisationTerminated
-
Lonza Ltd.CompletedHealthy Volunteers | Recovery | Endothelial FunctionGermany
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedLymphomaUnited States, Puerto Rico